Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: Study of 40 consecutive cases

Current Medical Research and Opinion

Volumn 25, Issue 11, 2009, Pages 2737-2743

  Hans, Guy ^a,b   Joukes, Ellen ^a   Verhulst, Johanna ^a   Vercauteren, Marcel ^a,b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Chronic post surgical pain; Chronic post traumatic pain; LANNS score; Lidocaine 5 patch; Neuropathic pain; Visual analogue score

Indexed keywords

LIDOCAINE; UNCLASSIFIED DRUG; VERSATIS;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; INJURY; MALE; NEUROPATHIC PAIN; OPEN STUDY; PAIN ASSESSMENT; POSTOPERATIVE PAIN; POSTTRAUMATIC PAIN; PROSPECTIVE STUDY; SKIN MANIFESTATION; SURGICAL INJURY; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; NEURALGIA; OSMOLAR CONCENTRATION; PAIN, POSTOPERATIVE; RESEARCH DESIGN; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 72549100781     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903282297     Document Type: Article

References (45)

1. Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009;32:1-32
2. Shipton E. Post-surgical neuropathic pain. ANZ J Surg 2008;78:548-555
3. Reuben SS. Chronic pain after surgery: what can we do to prevent it. Curr Pain Headache Rep 2007;11:5-13 (Pubitemid 46157579)
4. Vadivelu N, Schreck M, Lopez J, et al. Pain after mastectomy and breast reconstruction. Am Surg 2008;74:285-296
5. Massaron S, Bona S, Fumagalli U, et al. Long-term sequelae after 1,311 primary inguinal hernia repairs. Hernia 2008;12:57-63 (Pubitemid 351234440)
6. Wildgaard K, Ravn J, Kehlet H. Chronic post-thoracotomy pain: a critical review of pathogenic mechanisms and strategies for prevention. Eur J Cardiothorac Surg 2009;36:170-180
7. Vissers KC. The clinical challenge of chronic neuropathic pain. Disabil Rehabil 2006;28:343-349 (Pubitemid 43307457)
8. Wallace MS, Wallace AM, Lee J, et al. Pain after breast surgery: a survey of 282 women. Pain 1996;66:195-205 (Pubitemid 26283988)
9. Perttunen K, Tasmuth T, Kalso E. Chronic pain after thoracic surgery: a follow-up study. Acta Anaesthesiol Scand 1999;43:563-567 (Pubitemid 29232726)
10. Gjeilo KH, Klepstad P, Wahba A, et al. Chronic pain after cardiac surgery: a prospective study. Acta Anaesthesiol Scand 2009 Aug 13 [Epub ahead of print]
11. Perkins FM, Kehlet H. Chronic pain as an outcome of surgery. A review of predictive factors. Anesthesiology 2000;93:1123-1133
12. van Hanswijck de Jonge P, Lloyd A, Horsfall L, et al. The measurement of chronic pain and health-related quality of life following inguinal hernia repair: a review of the literature. Hernia 2008;12:561-569
13. Vadalouca A, Siafaka I, Argyra E, et al. Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment. Ann N Y Acad Sci 2006;1088:164-186 (Pubitemid 47092037)
14. Katz NP, Gammaitoni AR, Davis MW, et al. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial. Pain Med 2002;3:324-332
15. Binder A, Bruxelle J, Rogers P, et al. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Invest 2009;29:393-408
16. Hans G, Sabatowski R, Binder A, et al. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin 2009;25:1295-1305
17. Nayak S, Cunliffe M. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases. Paediatr Anaesth 2008;18:554-558 (Pubitemid 351600183)
18. Hans GH, Robert DN, Van Maldeghem KN. Treatment of an acute severe central neuropathic pain syndrome by topical application of lidocaine 5% patch: a case report. Spinal Cord 2008;46:311-313
19. Nalamachu S, Crockett RS, Gammaitoni AR, et al. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-week, randomized, parallelgroup study. MedGenMed 2006;8:33 (Pubitemid 44237007)
20. Herrmann DN, Barbano RL, Hart-Gouleau S, et al. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med 2005;6:379-384 (Pubitemid 41727336)
21. Baron R, Mayoral V, Leijon G, et al. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 2009;25:1677-1687
22. Kivitz A, Fairfax M, Sheldon EA, et al. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis- related knee pain: post hoc analysis of a 12 wekk, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Clin Ther 2008;30:2366-2377
23. Baliki MN, Geha PY, Jabakhanji R, et al. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Mol Pain 2008;4:47
24. Gammaitoni AR, Galer BS, Onawola R, et al. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin 2004;20(Suppl 2):S13-19 (Pubitemid 40179646)
25. Fishbain DA, Lewis JE, Cole B, et al. Lidocaine 5% patch: an open-label naturalistic chronic pain treatment trial and prediction of response. Pain Med 2006;7:135-142
26. Gimbel J, Linn R, Hale M, Nicholson B. Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study. Am J Ther 2005;12:311-319 (Pubitemid 41391809)
27. Galer BS, Gammaitoni AR, Oleka N, et al. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin 2004;20(Suppl 2):S5-12 (Pubitemid 40179645)
28. Habib AS, Polascik TJ, Weizer AZ, et al. Lidocaine patch for postoperative analgesia after radical retropubic prostatectomy. Anesth Analg 2009;108:1950-1953
29. Cheville AL, Sloan JA, Northfelt DW, et al. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phaseIII double-blind crossover study (N01CB). Support Care Cancer 2009;17:451-460
30. Jagetia GC, Rao SK, Baliga MS, et al. The evaluation of nitric oxide scavenging activity of certain herbal formulations in vitro: a preliminary study. Phytother Res 2004;18:561-565 (Pubitemid 39079154)
31. Hans G, Masquelier E, De Cock P. The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational study. BMC Public Health 2007;7:170 (Pubitemid 47252357)
32. Dajczman E, Gordon A, Kreisman H, et al. Long-term postthoracotomy pain. Chest 1991;99:270-274
33. Sihoe AD, Lee TW, Wan IY, et al. The use of gabapentin for post-operative and post-traumatic pain in thoracic surgery patients. Eur J Cardiothorac Surg 2006;29:795-799
34. Bartlett EE, Hutaserani Q. Lidocaine (xylocaine) for the relief of postoperative pain. J Am Med Womens Assoc 1962;17:809-815
35. Boas RA, Covino BG, Shahnarian A. Analgesic responses to i.v. lignocaine. Br J Anaesth 1982;54:501-505
36. Cassuto J, Wallin G, Hogstrom S, et al. Inhibition of postoperative pain by continuous low-dose intravenous infusion of lidocaine. Anesth Analg 1985;64:971-974 (Pubitemid 16236622)
37. Mao J, Chen LL. Systemic lidocaine for neuropathic pain relief. Pain 2000;87:7-17 (Pubitemid 30345657)
38. Nagaro T, Shimizu C, Inoue H, et al. [The efficacy of intravenous lidocaine on various types of neuropathic pain]. Masui 1995;44:862-867
39. Brose WG, Cousins MJ. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain 1991;45:145-148
40. Wilcke JR, Davis LE, Neff-Davis CA, et al. Pharmacokinetics of lidocaine and its active metabolites in dogs. J Vet Pharmacol Ther 1983;6:49-57
41. Wallace MS. Calcium and sodium channel antagonists for the treatment of pain. Clin J Pain 2000;16(2 Suppl):S80-5
42. Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002;36:236-240
43. Cuello AC, Polak JM, Pearse AG. SubstanceP: a naturally occurring transmitter in human spinal cord. Lancet 1976;2:1054-1056
44. Oku R, Satoh M, Takagi H. Release of substanceP from the spinal dorsal horn is enhanced in polyarthritic rats. Neurosci Lett 1987;74:315-319 (Pubitemid 17017962)
45. Yaksh TL. Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res 1988;458:319-324